Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma

LESSONS LEARNED: Trials focusing on unresectable multifocal glioblastoma are needed because of the extremely poor prognosis and challenges in receiving standard therapy, such as concurrent radiation and chemotherapy. Developing a strategy to chemically debulk tumors before radiation and/or surgery i...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncologist
Auteurs principaux: Peters, Katherine B., Lou, Emil, Desjardins, Annick, Reardon, David A., Lipp, Eric S., Miller, Elizabeth, Herndon, James E., McSherry, Frances, Friedman, Henry S., Vredenburgh, James J.
Format: Artigo
Langue:Inglês
Publié: AlphaMed Press 2015
Sujets:
Clinical Trial Results
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4492239/
https://ncbi.nlm.nih.gov/pubmed/26025933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0135
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires